title: Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets.
abstract: Approximately 60% of transplanted islets undergo apoptosis within the first week post-transplantation into the liver attributed to poor engraftment, immune rejection and toxicity of immunosuppressive drugs. Understanding how extracellular matrix (ECM) components, immunosuppressive drugs and proinflammatory cytokines affect insulin secretion will contribute to an improved clinical outcome of islet transplantations. In this study, functional activity of isolated murine islets was measured by glucose-stimulated insulin secretion (GSIS) and by electrophysiological measurements using patch-clamp. Cultivating islets with soluble fibronectin or laminin, as opposed to with coated laminin, markedly increased GSIS. Addition of cyclosporin A reduced GSIS and suppressed glucose-induced spike activity. Tacrolimus affected neither GSIS nor spike activity, indicating a different mechanism. To evaluate the influence of proinflammatory cytokines, islets were incubated with interleukin (IL)-1β, tumour necrosis factor (TNF)-α or with supernatants from cultured Kupffer cells, the main mediators of inflammation in the hepatic sinusoids. IL-1β exerted a bimodal effect on insulin secretion, stimulating below 2 ng/ml and suppressing above 10 ng/ml. Soluble laminin in combination with a stimulatory IL-1β concentration further increased insulin secretion by 20% compared to IL-1β alone, while with high IL-1β concentrations soluble laminin slightly attenuated GSIS inhibition. TNF-α alone did not affect GSIS, but with stimulatory IL-1β concentrations completely abolished it. Similarly, supernatants derived from Kupffer cells exerted a bimodal effect on GSIS. Our data suggest that improved insulin secretion of transplanted islets could be achieved by including soluble laminin and low IL-1β concentrations in the islet cultivation medium, and by a simultaneous inhibition of cytokine secretion from Kupffer cells.
authors.affiliation: Institute of Medical Engineering, Technische Universität München (IMETUM), Garching Center for Liver Cell Research, Department of Pediatrics and Adolescent Medicine, University of Regensburg Hospital Hepacult GmbH, Biopark Regensburg, Regensburg, Switzerland. veronika.auer@mytum.de
authors.forename: V J
authors.initials: VJ
authors.lastname: Auer
authors.forename: E
authors.initials: E
authors.lastname: Janas
authors.forename: V
authors.initials: V
authors.lastname: Ninichuk
authors.forename: E
authors.initials: E
authors.lastname: Eppler
authors.forename: T S
authors.initials: TS
authors.lastname: Weiss
authors.forename: S
authors.initials: S
authors.lastname: Kirchner
authors.forename: A M
authors.initials: AM
authors.lastname: Otto
authors.forename: M J
authors.initials: MJ
authors.lastname: Stangl
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D016572:Cyclosporine / Q000494:pharmacology; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D005353:Fibronectins / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007249:Inflammation / Q000378:metabolism; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D053583:Interleukin-1beta / Q000494:pharmacology; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D016381:Islets of Langerhans Transplantation; D007728:Kupffer Cells / Q000378:metabolism; D007797:Laminin / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D016559:Tacrolimus / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D005353:Fibronectins; D007166:Immunosuppressive Agents; D007328:Insulin; D053583:Interleukin-1beta; D007797:Laminin; D014409:Tumor Necrosis Factor-alpha; D016572:Cyclosporine; D005947:Glucose; D016559:Tacrolimus